Dr. Arianna Bassan, PhD in Chemical Physics, is a European Registered Toxicologist (ERT) and chartered chemist. With international experience at Stockholm University, MSD/Merck&Co., and the European Commission, she co-founded Innovatune, specializing in human health hazard assessment through the combination of traditional toxicology and AI-driven in silico tools.She has led global expert networks, including industry collaborations for example onweight-of-evidence approach for carcinogenicity assessment. Her collaboration with health authorities underscores her contributions to regulatory science. She has authored numerous toxicity reports and peer-reviewed articles.

Dr. Andreas M Papas is Adjunct Professor of the College of Medicine, East Tennessee State University and CEO and member of the Board of Directors of Antares Health Products, Inc. A Fulbright Scholar, Dr. Papas is a graduate of the University of Illinois and author of The Vitamin E Factor paperback and editor of the scientific book Antioxidant Status, Diet, Nutrition and Health. Dr Papas developed product concepts and managed formulation, clinical evaluation supported by the National Institutes of Health and the Cystic Fibrosis Foundation, stability and safety testing, pilot, and commercial production.

Dr. Claudia Cusan was born nearby Venice (Italy), and completed her master's and doctoral degrees in Pharmaceutical Chemistry at the University of Trieste (Italy). After the PhD, she moved to the Netherlands, where she worked in the pharmaceutical business unit of Royal DSM, first as R&D scientist and then as project manager. Her research focused on the development of new chemo-enzymatic strategies for the synthesis of generics APIs, and the preparation of new biomaterials for medical devices. Then she registered as European Toxicologist and became Global Corporate Toxicologist at Royal DSM, with global responsabilities for the company strategy in the area of toxicology and product safety. In 2017 she returned to Italy, where she founded S&C BEST Srl, a consultancy compay specialized in toxicology, supporting firms active in different sector as: pharmaceutical products, cosmetic formulations, medical devices, food contact materials, polymers. In 2023 S&C BEST Srl earned the membership of the Corporate Program at Eurotox. Dr. Claudia Cusan is member of Italian Association Business Operators in Food Contact Material (AIBO), and member of External Committee of the master’s degree in Pharmaceutical Chemistry at University of Trieste.

Rassa Pegahi holds a Ph.D. in Molecular and cell Biology and brings extensive of hands-on experience in oncology from a hospital environment before joining the pharmaceutical industry. Currently, Dr. Pegahi is pursuing her career in the pharmaceutical industry as a specialist in medical affairs & clinical trials.

Professor of Toxicology in Drug Discovery and Development at the Technical University of Kaiserslautern, Germany, with over 30 years of experience in the pharmaceutical industry. He has held significant roles at Novartis and Janssen (JNJ), focusing on mechanistic and investigative toxicology. A board-certified toxicologist, he has served as a scientific advisor and board member for various international organizations. Prof. Wolf co-founded and served as interim CEO of TransHeps AG and was the Chief Scientific Officer (CSO) at InSphero, a leading company in 3D-cell-based organ-on-a-chip technology and microphysiological systems (MPS). He is a respected leader in industrial in vitro toxicology, particularly in Drug-induced Liver Injury (DILI)

Dr. Eugene Zadorin is a highly accomplished expert with over 20 years of experience addressing toxicological challenges through innovative research and applied solutions. He holds a PhD and has devoted his career to advancing biotechnological approaches for evaluating and mitigating the toxicological risks of pharmaceuticals, industrial compounds, and environmental agents. His work bridges pharmacology and toxicology, with a focus on drug safety, biomarker development, and the creation of advanced biotechnological platforms for toxicity testing. His research has contributed significantly to the understanding of molecular mechanisms underlying adverse drug reactions and environmental exposures. As a leader in his field, he has authored more than 50 peer-reviewed publications and book chapters and has presented his findings at major international conferences. He serves as an advisor to regulatory bodies and industry stakeholders, helping shape strategies for safer drug development and sustainable biotechnological practices. Currently, he is the Director of a cutting-edge research laboratory, where he leads a multidisciplinary team in tackling toxicological problems through biotechnological innovation. He is also committed to mentoring young scientists and fostering global collaborations to advance health and safety in the pharmacological and biotechnological sciences.

Professor of Toxicology in Drug Discovery and Development at the Technical University of Kaiserslautern, Germany, with over 30 years of experience in the pharmaceutical industry. He has held significant roles at Novartis and Janssen (JNJ), focusing on mechanistic and investigative toxicology. A board-certified toxicologist, he has served as a scientific advisor and board member for various international organizations. Prof. Wolf co-founded and served as interim CEO of TransHeps AG and was the Chief Scientific Officer (CSO) at InSphero, a leading company in 3D-cell-based organ-on-a-chip technology and microphysiological systems (MPS). He is a respected leader in industrial in vitro toxicology, particularly in Drug-induced Liver Injury (DILI).

Dr. Claudia Cusan was born nearby Venice (Italy), and completed her master's and doctoral degrees in Pharmaceutical Chemistry at the University of Trieste (Italy). After the PhD, she moved to the Netherlands, where she worked in the pharmaceutical business unit of Royal DSM, first as R&D scientist and then as project manager. Her research focused on the development of new chemo-enzymatic strategies for the synthesis of generics APIs, and the preparation of new biomaterials for medical devices. Then she registered as European Toxicologist and became Global Corporate Toxicologist at Royal DSM, with global responsabilities for the company strategy in the area of toxicology and product safety. In 2017 she returned to Italy, where she founded S&C BEST Srl, a consultancy compay specialized in toxicology, supporting firms active in different sector as: pharmaceutical products, cosmetic formulations, medical devices, food contact materials, polymers. In 2023 S&C BEST Srl earned the membership of the Corporate Program at Eurotox. Dr. Claudia Cusan is member of Italian Association Business Operators in Food Contact Material (AIBO), and member of External Committee of the master’s degree in Pharmaceutical Chemistry at University of Trieste.

Dr. Eugene Zadorin is a highly accomplished expert with over 20 years of experience addressing toxicological challenges through innovative research and applied solutions. He holds a PhD and has devoted his career to advancing biotechnological approaches for evaluating and mitigating the toxicological risks of pharmaceuticals, industrial compounds, and environmental agents. His work bridges pharmacology and toxicology, with a focus on drug safety, biomarker development, and the creation of advanced biotechnological platforms for toxicity testing. His research has contributed significantly to the understanding of molecular mechanisms underlying adverse drug reactions and environmental exposures. As a leader in his field, he has authored more than 50 peer-reviewed publications and book chapters and has presented his findings at major international conferences. He serves as an advisor to regulatory bodies and industry stakeholders, helping shape strategies for safer drug development and sustainable biotechnological practices. Currently, he is the Director of a cutting-edge research laboratory, where he leads a multidisciplinary team in tackling toxicological problems through biotechnological innovation. He is also committed to mentoring young scientists and fostering global collaborations to advance health and safety in the pharmacological and biotechnological sciences.

Ilya B. Tsyrlov, MD, has completed his PhD in Biochemistry at the age of 27, and thereafter – a higher degree Doctor of Science in Molecular Pharmacology. He has been working as Head of the laboratory, Department Chair at Russian Academy of Science. In the United States, Tsyrlov served a Senior Research Fellow at NCI/NIH, and a Research Professor at Mount Sinai School of Medicine. Since 2005, a President/CSO of the XENOTOX, Inc, USA. Incepted and developed the Xenovirology, an interdisciplinary biomedical field, and prioritized modifications of analgesics, synthetic opioids and antimalarials thus developing long-acting drug delivery formulations. He is the author of 6 monographs and 300+ peer reviewed publications, and has been serving as an editorial board member of repubted journals.

Dr. Andreas M Papas is Adjunct Professor of the College of Medicine, East Tennessee State University and CEO and member of the Board of Directors of Antares Health Products, Inc. A Fulbright Scholar, Dr. Papas is a graduate of the University of Illinois and author of The Vitamin E Factor paperback and editor of the scientific book Antioxidant Status, Diet, Nutrition and Health. Dr Papas developed product concepts and managed formulation, clinical evaluation supported by the National Institutes of Health and the Cystic Fibrosis Foundation, stability and safety testing, pilot, and commercial production.

Dr. Jay Ingram is the Director, Chemicals at Humane Society International and has over 15 years experience in the toxicological risk assessment and regulatory compliance of chemicals and consumer products using both traditional and Next Generation Risk Assessment (NGRA) approaches. Jay is a toxicologist by training and started his career at Unilever where he was introduced to using non-animal methods of safety assessment. Whilst working for Delphic HSE Jay authored the forthcoming Global Regulatory Landscape module as part of the Animal Free Safety Assessment (AFSA) Collaboration’s Master Class. Recently Jay has made the transition from industry to NGO to contribute his knowledge and experience to the work of ultimately phasing-out animal testing for chemicals and consumer products.

Dr. Arianna Bassan, PhD in Chemical Physics, is a European Registered Toxicologist (ERT) and chartered chemist. With international experience at Stockholm University, MSD/Merck&Co., and the European Commission, she co-founded Innovatune, specializing in human health hazard assessment through the combination of traditional toxicology and AI-driven in silico tools.She has led global expert networks, including industry collaborations for example onweight-of-evidence approach for carcinogenicity assessment. Her collaboration with health authorities underscores her contributions to regulatory science. She has authored numerous toxicity reports and peer-reviewed articles.

Mr. Chartrand is an environmental scientist and toxicologist located in Seattle, WA, USA. His key areas of technical expertise relate to toxicology (especially ecotoxicology) and risk assessment, focusing on ecological and human health risk assessment, water qualityissues, Clean Water Act (CWA) regulations, and contaminated sediments. He is a former water quality regulatory scientist for the Los Angeles Regional Water Quality Control Board in California, where he led a team that discovered and field-verified that large quantities of DDT as well as other wastes were ocean-dumped in deeper waters near southern California. He most recently published a Synthesis Report summarizing and reviewing what is known of these continuing marine ecological and toxicological effects of DDT. He completed his undergraduate work in biology at UC Berkeley, and graduate work in toxicology at UCLA. He was also Board-certified as a Diplomate by the American Board of Toxicology (DABT).

Dr. Wei Wu serves as Deputy Dean of the School of International Education, Deputy Director of the Department of International Cooperation and Exchange, Professor of the Department of Toxicology at Nanjing Medical University, China. He was a guest researcher at the National Institute of Environmental Health Sciences (NIEHS) between 2017 and 2018. He is the PI of the State Key Laboratory of Reproductive Medicine andOffspring Health, and the Key Laboratory of Modern Toxicology of the Ministry of Education. He is a member of different national and international societies in the fields of human reproduction and toxicology, and has received awards from many national societies for the originality and quality of his projects. He has a wide range of teaching and consulting experience, including in toxicology. His research interests include the application of new media technology in teaching, epigenetic mechanisms of transgenerational effects of male infertility induced by endocrine disrupting chemicals, environmental exposure and male reproductive health, genetic and epigenetic risk factors of male infertility and abnormal fetal growth.

Dr. Rassa Pegahi holds a Ph.D. in Molecular and cell Biology and brings extensive of hands-on experience in oncology from a hospital environment before joining the pharmaceutical industry. Currently, Dr. Pegahi is pursuing her career in the pharmaceutical industry as a specialist in medical affairs & clinical trials.

Valeria Cardinale is an experienced regulatory affairs professional with a degree in Chemistry from the University of Rome “La Sapienza.” Since 2006, she has been the Coordinator of the Quality group at Di Renzo Regulatory Affairs, specializing in regulatory strategies, medicinal product registration, and compliance with European and national legislation. With expertise in quality assurance, lifecycle management, and environmental control, Valeria has a proven track record in supporting pharmaceutical and environmental projects. Fluent in Italian and proficient in English, she combines technical knowledge with strong problem-solving and communication skills to deliver effective regulatory solutions.